JOURNAL OF BUON, cilt.15, sa.2, ss.248-254, 2010 (SCI-Expanded, Scopus)
Purpose: To investigate the efficacy and safety of neoadjuvant chemotherapy with docetaxel plus epirubicin with granulocyte colony-stimulating factor (G-CSF) support in locally advanced breast cancer patients.